The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
OV21/PETROC: A randomized Gynecologic Cancer Intergroup (GCIG) phase II study of intraperitoneal (IP) versus intravenous (IV) chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer (EOC).
 
Helen Mackay
Travel, Accommodations, Expenses - AstraZeneca
 
Christopher J. Gallagher
Honoraria - Amgen
Consulting or Advisory Role - Amgen
Speakers' Bureau - Amgen
 
Wendy R. Parulekar
No Relationships to Disclose
 
Jonathan A. Ledermann
Consulting or Advisory Role - AstraZeneca/MedImmune (Inst); Clovis Oncology (Inst)
Research Funding - AstraZeneca (Inst)
 
Deborah Kay Armstrong
Consulting or Advisory Role - Eisai (I); Morphotek; Vertex
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Eisai (I); Exelixis (I)
Other Relationship - FDA
 
Charlie Gourley
Honoraria - AstraZeneca; Roche/Genentech
Consulting or Advisory Role - AstraZeneca (Inst); Clovis Oncology (Inst); Nucana (Inst)
Research Funding - AstraZeneca (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - One patent issued and four pending for a gene expression signature to predict cancer sensitivity to anti-angiogenic therapy. (Inst)
 
Ignacio Romero
Speakers' Bureau - AstraZeneca; Roche
 
Amanda Feeney
No Relationships to Disclose
 
Paul Bessette
Consulting or Advisory Role - AstraZeneca; Merck; Roche
Speakers' Bureau - Merck; Roche
Research Funding - Abbvie; Amgen; Array BioPharma; AstraZeneca; Boehringer Ingelheim; Endocyte; Merck; Roche; Tesaro
 
Marcia Hall
No Relationships to Disclose
 
Johanne Ingrid Weberpals
Honoraria - AstraZeneca; Boehringer Ingelheim
 
Geoff Hall
Honoraria - Philips Healthcare
Consulting or Advisory Role - Philips Healthcare
Research Funding - Philips Healthcare
 
Susie K Lau
No Relationships to Disclose
 
Philippe Gauthier
No Relationships to Disclose
 
Michael Fung-Kee-Fung
Honoraria - AstraZeneca; Roche
Consulting or Advisory Role - AstraZeneca; Roche
 
Elizabeth A. Eisenhauer
No Relationships to Disclose
 
Chad Winch
No Relationships to Disclose
 
Dongsheng Tu
No Relationships to Disclose
 
Diane M. Provencher
Leadership - AstraZeneca
Honoraria - AstraZeneca; Roche/Genentech
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - Roche/Genentech